Learn about our latest developments!
Keep up to date with our latest news, acquisitions, product launches & business news here.
Juno Pharmaceuticals Corp. is pleased to announce that it has secured a significant growth capital investment from New-York-based global healthcare equity firm, Signet Healthcare Partners. Through this investment, Signet will help fuel the continued rapid acceleration of Juno’s complex and high-value generic and biosimilar portfolio in Canada, while also joining the company’s Board of […]